L1 Capital’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-50,230	Closed	-$11.6M	–	14
2023 Q4	$11.6M	Buy	50,230 +1,761	+4%	+$308K	1.09%	12
2023 Q3	$7.08M	Buy	48,469 +2,730	+6%	+$514K	0.6%	12
2023 Q2	$10.6M	Buy	+45,739	New	+$12.4M	1.27%	13
2023 Q1	–	Sell	-133,312	Closed	-$38.7M	–	13
2022 Q4	$38.7M	Sell	133,312 -27,851	-17%	-$2.72M	5.97%	8
2022 Q3	$10.5M	Sell	161,163 -6,840	-4%	-$475K	2.05%	10
2022 Q2	$10.6M	Sell	168,003 -47,313	-22%	-$3.48M	2.06%	11
2022 Q1	$15.1M	Buy	215,316 +47,655	+28%	+$4.02M	1.83%	10
2021 Q4	$14.2M	Buy	167,661 +2,801	+2%	+$230K	1.64%	13
2021 Q3	$13.2M	Hold	164,860	–	–	1.64%	13
2021 Q2	$16.1M	Buy	164,860 +52,256	+46%	+$6.19M	3.32%	9
2021 Q1	$13.2M	Sell	112,604 -860	-0.8%	-$100K	3.31%	9
2020 Q4	$12.6M	Sell	113,464 -1,197	-1%	-$146K	2.35%	13
2020 Q3	$13.6M	Sell	114,661 -2,670	-2%	-$290K	4.37%	7
2020 Q2	$13.3M	Buy	+117,331	New	+$11.5M	4.54%	8